Profilo
Eric Meldrum is currently the Chief Scientific Officer at ENYO Pharma SA and Citryll BV.
He previously held the position of Chief Scientific Officer at Calliditas Therapeutics Suisse SA.
Posizioni attive di Eric Meldrum
| Società | Posizione | Inizio |
|---|---|---|
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutic products to treat autoimmune and other human diseases | Direttore Tecnico/Scientifico/R&S | 29/08/2023 |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Eric Meldrum
| Società | Posizione | Fine |
|---|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutic products to treat autoimmune and other human diseases | Commercial Services |
















